Ventas, Inc. (NYSE:VTR – Get Free Report) EVP Carey Roberts sold 35,532 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the transaction, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Ventas Stock Performance
NYSE:VTR traded down $0.06 during mid-day trading on Friday, reaching $85.15. The stock had a trading volume of 4,344,080 shares, compared to its average volume of 3,037,968. Ventas, Inc. has a twelve month low of $60.15 and a twelve month high of $87.20. The business has a 50 day simple moving average of $78.45 and a 200 day simple moving average of $73.68. The firm has a market capitalization of $40.44 billion, a price-to-earnings ratio of 157.68, a PEG ratio of 2.09 and a beta of 0.77. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.32 and a current ratio of 0.67.
Ventas (NYSE:VTR – Get Free Report) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period last year, the company posted $0.81 earnings per share. The business’s quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, analysts expect that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.
Ventas Increases Dividend
Wall Street Analyst Weigh In
A number of research analysts have issued reports on VTR shares. Scotiabank increased their target price on shares of Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a report on Thursday, November 13th. UBS Group restated a “neutral” rating and issued a $85.00 price target on shares of Ventas in a report on Monday. Citigroup lifted their price objective on Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday. Royal Bank Of Canada upped their target price on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a report on Tuesday. Finally, Wells Fargo & Company lifted their price target on Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $86.31.
Get Our Latest Report on Ventas
Institutional Investors Weigh In On Ventas
Hedge funds have recently modified their holdings of the company. Cloud Capital Management LLC acquired a new stake in Ventas in the 3rd quarter valued at $25,000. GoalVest Advisory LLC purchased a new stake in shares of Ventas during the 4th quarter valued at about $26,000. Wiser Advisor Group LLC acquired a new position in Ventas during the 3rd quarter worth approximately $27,000. True Wealth Design LLC boosted its holdings in Ventas by 1,557.7% in the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after acquiring an additional 405 shares during the period. Finally, IFC & Insurance Marketing Inc. acquired a new stake in Ventas in the fourth quarter valued at approximately $30,000. 94.18% of the stock is owned by institutional investors and hedge funds.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
